Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 20.97 | N/A |
| PEG Ratio (TTM) | -0.77 | N/A |
| P/S Ratio (TTM) | 7.00 | N/A |
| P/B Ratio (TTM) | 1.00 | N/A |
| P/FCF Ratio (TTM) | 11.73 | N/A |
| Price to 5YR AVG Earnings Ratio | 25.09 | N/A |
| Price to 5YR AVG FCF Ratio | 14.98 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.71% | N/A |
| ROE (TTM) | 4.68% | N/A |
| Net Profit Margin (TTM) | 33.19% | N/A |
| ROIC 5YR AVG | 4.88% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 201.14% | 18.43% | 16.72% |
| Revenue | -0.22% | 17.50% | 13.52% |
| Net Income | 193.31% | 26.34% | 25.12% |
| Cash Flow | -1.41% | 24.47% | 16.77% |
Health (72%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 37.79 | N/A |
| Quick Ratio (TTM) | 37.79 | N/A |
| D/E Ratio (TTM) | 0.65 | N/A |
| Interest Coverage (TTM) | 4.91 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 1.91 | N/A |
| LTL to 5YR AVG FCF | 9.51 | N/A |
| Shares Outstanding Growth 5YR AVG | 5.60% | N/A |